Add Trial
Sign In

MK-3475-091/KEYNOTE-091 (PEARLS) - Hosted By

Sponsor Name
Tumor Site NSCLC - Non Small Cell Lung Cancer
Disease Stage Stage I, Stage II, Stage III
Clinical Status Adjuvant, Operable
Phase Phase III
Intervention / Treatment Pembrolizumab versus Placebo
Research Site Charles-LeMoyne Hospital
Investigator Dre Flavia De Angelis
Telephone Number +1 (450) 466-5000
Study Start Date November 6, 2015
Study End Date February 2, 2024
Trial Status Recruitment


Working Hours :

Now Closed UTC - 4
  • MondayDay Off
  • TuesdayDay Off
  • WednesdayDay Off
  • ThursdayDay Off
  • FridayDay Off
  • SaturdayDay Off
  • SundayDay Off

Price / Claim :

Recruit a patient:

*for confidentiality, do not include the name of the patient

*pour raisons de confidentialité, n'incluez pas le nom du patient

Hosted by :

More from this author :

Claim listing: MK-3475-091/KEYNOTE-091 (PEARLS)

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Reply to Message


Please select an account type above.

Account details will be confirmed via email.

Register with us by filling out the form below.
Register with us by filling out the form below.

Reset Your Password